Design, Synthesis, and Evaluation of Polyamine Deacetylase Inhibitors, and High-Resolution Crystal Structures of Their Complexes with Acetylpolyamine Amidohydrolase.

  title={Design, Synthesis, and Evaluation of Polyamine Deacetylase Inhibitors, and High-Resolution Crystal Structures of Their Complexes with Acetylpolyamine Amidohydrolase.},
  author={C. Decroos and D. Christianson},
  volume={54 30},
Polyamines are essential aliphatic polycations that bind to nucleic acids and accordingly are involved in a variety of cellular processes. Polyamine function can be regulated by acetylation and deacetylation, just as histone function can be regulated by lysine acetylation and deacetylation. Acetylpolyamine amidohydrolase (APAH) from Mycoplana ramosa is a zinc-dependent polyamine deacetylase that shares approximately 20% amino acid sequence identity with human histone deacetylases. We now report… Expand
6 Citations
Binding of N8-Acetylspermidine Analogues to Histone Deacetylase 10 Reveals Molecular Strategies for Blocking Polyamine Deacetylation.
X-ray crystal structures of zebrafish HDAC10 complexed with eight different analogues of N8-acetylspermidine reveal interesting geometric changes in the metal coordination polyhedron that accommodate inhibitor binding. Expand
Structure and Function of the Acetylpolyamine Amidohydrolase from the Deep Earth Halophile Marinobacter subterrani.
The X-ray crystal structure of msAPAH, determined in complexes with 7 different inhibitors as well as the acetate coproduct, shows how the chemical strategy of Zn2+-dependent amide hydrolysis and the catalytic specificity for cationic polyamine substrates is conserved in a subterranean halophile. Expand
Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
This work sets a foundation for studying the chemical biology of autophagy through the structure-based design of inhibitors that may also serve as new leads for cancer chemotherapy. Expand
Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective.
This review has enumerated over one hundred of inhibitors targeting various metalloenzymes and identified over ten kinds of fragments with different binding patterns, which will provide deep insights for the rational design of novel inhibitors targeting the metal-containing binding sites of specific proteins. Expand
Biochemical and Structural Characterization of HDAC8 Mutants Associated with Cornelia de Lange Syndrome Spectrum Disorders
X-ray crystal structures of five human HDAC8 mutants reveal that each CdLS mutation causes structural changes that compromise catalysis and/or thermostability, and the catalytic activities of most mutants can be partially or fully rescued by the activator N-(phenylcarbamothioyl)-benzamide, suggesting thatHDAC8 activators may serve as possible leads in the therapeutic management of Cd LS. Expand
Structural aspects of HDAC8 mechanism and dysfunction in Cornelia de Lange syndrome spectrum disorders
Intriguingly, catalytic activity in many HDAC8 mutants can be partially or fully restored by an N‐acylthiourea activator, suggesting a plausible strategy for the chemical rescue of compromisedHDAC8 catalysis in vivo. Expand


Synthesis and evaluation of N⁸-acetylspermidine analogues as inhibitors of bacterial acetylpolyamine amidohydrolase.
The design, synthesis, and evaluation of N(8)-acetylspermidine analogues bearing different zinc binding groups as potential inhibitors of APAH are reported, to enable future explorations of acetylpolyamine function in both prokaryotes and eukaryotes. Expand
Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
Structural comparisons among HDACs and HDAC-related deacetylases reveal a conserved constellation of active site residues, suggesting a common mechanism for the metal-dependent hydrolysis of acetylated substrates. Expand
Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.
These structures, along with those of the D101N, D101E, D 101A, and D101L variants, support the proposal that D101 is critical for the function of the L2 loop and illustrate ligand-induced conformational changes in the L1 loop that likely accompany substrate binding and catalysis. Expand
Structure of prokaryotic polyamine deacetylase reveals evolutionary functional relationships with eukaryotic histone deacetylases.
The structure of APAH is the first of a histone deacetylase-like oligomer and reveals that an 18-residue insert in the L2 loop promotes dimerization and the formation of an 18 Å long "L"-shaped active site tunnel at the dimer interface, accessible only to narrow and flexible substrates. Expand
Synthesis of a new trifluoromethylketone analogue of l-arginine and contrasting inhibitory activity against human arginase I and histone deacetylase 8.
It is suggested that 10 represents a new lead in the design of an amino acid or peptide-based inhibitor of histone deacetylases with simpler structure than previously studied trifluoromethylketones. Expand
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
The structure of the histone deacetylase catalytic core is described, as revealed by the crystal structure of a homologue from the hyperthermophilic bacterium Aquifex aeolicus, and it is established that the residues that make up the active site and contact the inhibitors are conserved across the HDAC family. Expand
Structural basis of the antiproliferative activity of largazole, a depsipeptide inhibitor of the histone deacetylases.
The structure of the HDAC8-largazole thiol complex is the first to illustrate the mode of action of a new class of therapeutically important HDAC inhibitors, revealing that ideal thiolate-zinc coordination geometry is the key chemical feature responsible for its exceptional affinity and biological activity. Expand
Total synthesis and molecular target of largazole, a histone deacetylase inhibitor.
Full details of the concise and convergent synthesis of largazole, its extension to the preparation of a series of key analogues, and the molecular target and pharmacophore of largzole are described. Expand
Catalytic activity and inhibition of human histone deacetylase 8 is dependent on the identity of the active site metal ion.
It is demonstrated that histone deacetylase 8 (HDAC8) is catalytically active with a number of divalent metal ions in a 1:1 stoichiometry with the following order of specific activity, suggesting that Fe(II), rather than Zn(II) may be the in vivo catalytic metal. Expand
Activation and Inhibition of Histone Deacetylase 8 by Monovalent Cations*
It is demonstrated that one bound MVC activates catalytic activity of HDAC8, whereas the second, weaker-binding MVC decreases catalyst activity, suggesting that the site 2 MVC stabilizes an active conformation of the enzyme. Expand